Roche Holding AG said side effects in a highly anticipated study of its experimental obesity pill were milder when it eased patients into higher doses more slowly, seeking to reassure investors that ...
Positive opinion granted for KEYTRUDA plus chemotherapy for the first-line treatment of adult patients with primary advanced or recurrent endometrial carcinoma who are candidates for systemic therapy, ...